The increasing prevalence of SARS-CoV-2 variants with mutations in the spike protein has
raised concerns that recovered individuals may not be protected from reinfection and that …

Recently, a new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) lineage
called B. 1.1. 7 (variant of concern: VOC 202012/01), which is reported to spread more …

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) transmission is
uncontrolled in many parts of the world, compounded in some areas by higher transmission …

SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the
rollout of effective vaccines. Therefore, it is essential to understand the levels of protection …

As SARS-CoV-2 has been circulating for over a year, dozens of vaccine candidates are
under development or in clinical use. The BNT162b2 mRNA COVID-19 vaccine induces …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused the global
COVID-19 pandemic. Rapidly spreading SARS-CoV-2 variants may jeopardize newly …

BNT162b2 Vaccine and Emerging SARS-CoV-2 Variants A total of 20 serum samples from
15 persons who received the BNT162b2 vaccine showed strong neutralization activity …

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is the causative infection of
a global pandemic that has led to more than 2 million deaths worldwide. The Moderna …

Abstract The B. 1.617 variant emerged in the Indian state of Maharashtra in late 2020 and
has spread throughout India and to at least 40 countries. There have been fears that two key …

Highly transmissible SARS-CoV-2 variants recently identified in India designated B. 1.617
and B. 1.618 have mutations within the spike protein that may contribute to their increased …